Showing 2,657 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C treatment

Delay HCV Tx and Watch Patients Die

Editor's pick
MedPage Today
2 March 2015
Hepatitis C treatment

Doctor Panel to Weigh Hepatitis C Drugs’ Costs in Guidelines

Editor's pick
Bloomberg
2 March 2015
Hepatitis & HIV

Two interferon-free regimens show high HCV cure rates for people with HIV and HCV co-infection

News
27 February 2015
Hepatitis C treatment

NICE guidance recommends sofosbuvir (Sovaldi, Gilead Sciences) and simeprevir (Olysio, Janssen) for treating hepatitis C

Editor's pick
NICE press release
26 February 2015
New & experimental hepatitis C treatment

New hepatitis C treatments highly effective for HIV/HCV coinfected people

Editor's pick
HIVandHepatitis.com
26 February 2015
Hepatitis C transmission & prevention

Sexual Transmission of HCV in Gay Men Should Not Be a PrEP Deterrent, Say Advocates

Editor's pick
The Body
26 February 2015
Hepatitis C transmission & prevention

Clinicians report two acute HCV infections in Kaiser San Francisco PrEP programme

News
22 February 2015
Hepatitis C treatment

Cost-Effectiveness of Immediate Hepatitis C Treatment in Early Disease Analyzed

Editor's pick
HCP Live
20 February 2015
Hepatitis C treatment

amfAR Report Examines Controversial Pricing of Hepatitis C Treatment

Editor's pick
amfAR
19 February 2015
Pharmaceutical industry

The Drug That Is Bankrupting America

Editor's pick
Huffington Post
18 February 2015
Hepatitis C symptoms & diagnosis

Study: Door-to-door campaign linked hepatitis C patients to care

Editor's pick
Eurekalert Inf Dis
16 February 2015
Pharmaceutical industry

Healthcare: The race to cure rising drug costs

Editor's pick
Financial Times
13 February 2015
New & experimental hepatitis C treatment

Health News Review analysis of Reuters' coverage of new hepatitis C drugs

Editor's pick
Health News Review
13 February 2015
Access to healthcare

UNITAID: 2015 Hepatitis C medicines technology and market landscape

Editor's pick
UNITAID
13 February 2015
Hepatitis C treatment

Gilead agrees 41,000 euro hep-C drug price for 12 week treatment in Germany

Editor's pick
Reuters
13 February 2015
Hepatitis C treatment

Gilead expects big increase in Europeans treated with hep C drug

Editor's pick
Reuters
11 February 2015
New & experimental hepatitis C treatment

FDA revokes breakthrough status for BMS hep C drug

Editor's pick
Fierce Biotech
11 February 2015
New & experimental hepatitis C treatment

Regulus Therapeutics reports top-line results from RG-101 clinical study for HCV treatment

Editor's pick
Regulus Therapeutics press release
11 February 2015
Hepatitis C symptoms & diagnosis

Strategies for Slowing the Progression of Liver Fibrosis in Hepatitis C

Editor's pick
HCP Live
11 February 2015
HIV treatment

CROI 2015 Preview: New Research on HIV, Hepatitis C and Ebola

Editor's pick
The Body Pro
11 February 2015
Hepatitis C treatment

A more personalised approach to hepatitis C treatment may improve adherence and completion rates

News
11 February 2015
Access to healthcare

Gilead faces challenge to European patent on pricey hep C drug

Editor's pick
Reuters
10 February 2015
New & experimental hepatitis C treatment

Promising data bodes well for all-Achillion hep C treatment

Editor's pick
Reuters
10 February 2015
New & experimental hepatitis C treatment

Achillion Achieves 100% SVR12 in Phase 2 Trial Evaluating 6-Week Combination Treatment With ACH-3102

Editor's pick
Achillion press release
9 February 2015